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We have recently demonstrated that the decreased ability of hormones, fors~olin and GTP to stimulate adenylate eyclase m heart and aorta from 
~ponlaneously hypert~:n~lve rats (SHR), a:; compared to their age-matched Wistar-Kyoto control rats (WKY), was associated with enhanced levels 
of Gl- aiid not with Gs-regulatory proteins. In the present .qudies we have investigated the expresqon of Gi-legulatory proteins at the mRNA level 
by Northern blotting. Total RNA of heart ventricle and aorta fi'om WKY and SHR was probed wah radmlabeled eDNA m~erts encoding Gig-2 
and Gin-3. The Gi¢~-2 ,rod Gig-3 proben detected a message of 2-3 and 3-5 kb, ren~'ctively, inboth WKY attd SHR, however, the inessage was 
~iSififie,mtly enhanced in SHR, a~ compared by WKY. On the other hand the eDNA probe encoding Gs a detected a message of 1.8 kb in heart 
and aorta from botl~ WKY and SHR, ~owever, no difference in the levels of Gsa mRNA was detected in SHR and WKY tissues. These results 
md~c,tte hat the mRNA level~ of Gig-2 a:~d G~:x-3 and not of Gs are ovcrexpre~sed m heart mad aorta from SIIR, which may be responsible for 
the increased levels o1' Gia. ~ shown earlier by immunoblottmg techmque~. It may be nuggested that the enhanced vascular tone and impaired cardiac 
eontractihty ~n hypertension may partly be the consequences of increased levels of Gi in heart and aorta. 
G-protein; mRNA; Heart; Aorta; Hypeltension 
1. INTRODUCTION 
Guanine nucleotide regulatory proteins (G-proteins) 
are a family of GTP-binding proteins that play an im- 
portant role in the regulation of a variety of signal 
transduction systems. One of these is the adenylate 
cyclase/cAMP system, which is composed of three com- 
ponents: receptor, catalytic subunit, and stimulatory 
(Gs) and inhibitory (Gi) G-proteins which mediate the 
stimulatory and inhibitory responses of hormones on 
adenylate cyclase, respectively [1-3]. G-proteins exist as 
heterotrimers of a, fl, ~, subanits, and the specificity of 
G-proteins is attributed to the g-subunits. These Gs~t 
and Gi~ subunits are known to be specifically ADP- 
ribosylated by cholera toxin and pertussis toxin, respec- 
tively [4]. Recently, molecular cloning has revealed four 
different forms of Gsg resulting from the differential 
splicing of one gone [5,6], and three di~tin~.t forms of 
Gig: Gi~l, Gio~2 and Gig3 encoded by three distinct 
genes [7-9]. 
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Gw:-I, mlula~tory guanine nuclcot~de regulatory protein; Gltx-l, Gw:-2, 
Gi~-3 isoforms of inhibitory guanine nuel~ol~do regulatory protein 
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~pontaneously hypertensive rats, mRNA, me.,,~enger ribonueleie; 
rRNA, ribosomal ribonuclele acid. 
The adenylate cyclase/cAMP system has been impli- 
cated in both the control of heart contractility [I0,11] 
and the tone of vascular smooth muscles [12,13]. We 
have previously reported that forskolin, guanine nude- 
otides and some hormones were less responsive to stim- 
ulate adenylate cyclase in heart sarcolemma and aorta 
from spontaneously h pertensive rats (SHR) as com- 
pared to their Wistar--Kyoto controls (WKY) [14], st,g- 
gesting that all three conal:onents of the adenylate 
cyclase system may be impaired in SHR. Further inves- 
tigations on G-proteins, using bacterial toxin-catalyzed 
ADP-ribosylations and immunoblotting techniques, 
have demonstrated nhanced levels ot" Gkx and not Gs~- 
protein in heart sarcolemma and aorta from SHR as 
compared to WKY rats, which were shown to be asso- 
crated with an augmented inhibitory response of 
hormones on adenylate cyclase activity [15]. 
In order to investigate whether the enhanced levels of 
Gin, as demonstrated previously in SHR, are transcrip- 
tionally regulated, we undertook the present studies and 
analyzed the mRNA expression of Gi-proteins in heart 
and aorta from SHR and WKY rats, using eDNA 
probes for G-binding proteins. 
2. MATERIALS AND METHODS 
2.1. AJztolals 
Male SHR and normoteas~ve WKY rats of 12 week~ ol" age were 
pardiased from Cl~arlcs River Canada (Saint Constant, Qu¢, Can- 
ada). Their blood pressure, measured by the tad cuff method without 
ane~thgsia, wan 98.5 ± 3.3 and 146.5 ± 5.9 mmH8 for WKY and SHR 
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groups, lc~pcctively. Body weights were 172.5 ± 1 9 and 196.4 ± i 9 
g, respeetwely. 
2.2. Materials 
Plasmid~ contami,a 8 rat cDNAs encoding Gl~2, Gi~z3 and Os~ were 
kindly obtained from Dr Randall Reed from the Johns Hopkins 
University, and Dr. Hiro~hi hoh from the Umver~ity ofTokyo. The 
32-met ollgonueleot~de which reeogntzes n lu~ly conserved regton m 
the 28 S ribosomal RNA wa~ kindly donated by D~. Yo~hihiro 
hh~kawa from Ledcrle Laboratory of New York. Chemicals necessary 
for total RNA extraction and Northern blot analyhis were obtained 
from Sigma Chemical Co. (St. Loum, Me, USA), except guanidiaium 
tluocyanate which wa~ fiom Re,earth Organics inc. (Cleveland, OH, 
USA), and glyoxal from BDH Ltd. (St. Lanrent, Qae., Canada). 
Enzymes a~ed for radiotabehng of eDNA probe~ were obtained from 
BRL (Burlington, Ont., Canada) aqd other chemicals were from Phar- 
macht Ltd. (Ba~e d'Urf~e, Que., Canada). Nylon filtei (Hybond-N), 
[0;-~'-P]dCTP (3,000 Cl/mmol) and [y-UP]ATP (3,000 Ci/mmol) were 
purchased from Amersham Corp. (Oakwlle, Ont., Canada). 
2 3. Total RNA e~tractton 
Total RNA wan isolated by the guanldinaan thioeyanate-phenol- 
ehlorolb~m ethod described by Cholnczynsk~ et al. [16]. Buefly, 
frozen aorta and heart ventricles were homogenized in a denaturatiag 
solution (soluuon D) containing 4 M guamdtnmn~ tluoeyanate, 25 
mM sodmm c~trate, pH 7 0, 0 5% sarkosyl and 0 1 M 2-mereaptoetha- 
nol The homogenate~ were extracted once with I vol, of plaenol and 
0.2 vol. of eloroform-i~oamylalcohol (49-1) in the presence of 0 2 M 
sodmm acetate, oH 4.0, and once with 1 vol ofchloroforln-~soamylal- 
eohol (49:1) Total RFI~, wa~ then precipitated with isop~opanol. 
Following asecond precipaatmn m ~olutton D and ~sopropanol (v'v), 
total RNA was washed in 70% ethanol and re~uspended m water. 
2.4 Radtolabehng of  the probe~' 
eDNA inserts encoding for Gi~t2, G~3 and G~ were radtolabeled 
with [~-~:P]dCTP by random priming es~entially a~described by Fein- 
berg etal. [17]. Specific aetivitie~ of the labeled probe~ ranged from 
l to 3 10 ~ epm/pg of DNA. The 32-met ohgonueleotide recognizing 
the 28 S rRNA was end-labeled w~th [7-~:P]ATP a~ing T4 polynucle- 
etude kinase a.~ described by Sambrook et ,~1. [18]. 
2 5. Northern attaly~ts 
DMSO/glyoxal-treated total RNA was re~olved on I% agaro~e gels 
and tranfferred to nylon membrane a~ dehcribed by Sambrook et al 
[19]. Filters, after prehybridlzauon at 650C for 6 h in hybrldlt.atlou 
solution (600 mM NaCI, B mM EDTA, 120 mM Tris, pH 74, 0 1% 
sodium pyrophosphate, 0.2% SDS and 500 U/ml heparm), 0.1% so. 
dium pyrophosphate, 0.2% SDS, hel~ann 500 U/ml, were hybridized 
ovei night in hybridization ~olutlon containing dextran sulphate (10% 
w/v) and the eDNA probe at 1-3.10 ~ epm/ml as described by Smgh 
et al. [20] Fdters were then rinsed at 65"C for 2 × 30 mm in 300 mM 
NaCI, 4 mM EDTA, 60 mM Tri.% pH 7.4, and 0.2% SDS, and 1 × 30 
rain in 150 mM NaCI, 2 mM EDTA, 30 mM Tr,s, pH 7.4, ann 0 1% 
SDS. Autoradlography was performed with X-ray fllna~ at -70°C. In 
order to a~ses~ the possibility of any variations m the amoums of total 
RNA in individual samples applied to the gel, each filter wan hybrid- 
reed with the ~=F end-labeled ohgonuclcotlde, which recognizes a
highly eonserv¢~J l¢gion of 28 S ribosomal RNA. The blots which had 
been probed with the G-prote!n eDNA were de-hybridized by washing 
for 1 h at 65°C in 50% formamide, 300 mM NaCl, 4 mM EDT~- and 
60 mM Tri.~, pH 7.4, and re-hybridlzed o ~ern =ght at room temperature 
with the oligonueleotlde. Quantitauve analysl~ ofthe hybridization f 
probe~ buat,d wa~ perlb~ed by densitometrie sca:'.ning orthe autora- 
d=ograph~ employing the enhane~.~l la~er dens=remoter, LKB UI- 
trosean XL and quanufied using the gel scan XL evaluation software 
(vers,on 2.1) from Plmrmac=a (Qnc., Canada). 
TOTAL RNA (i~g) 
28 S - -  
HEART HEART 
WKY @HR ~ 
13 13 8 8 
28 S - -  
18S - -  185  - -  
I I 1 )  
A B 
Fig 1. mRNA expresuon of Gich2 and Gig3 in heart ventricles from 
3HR and WKY rat~. Total RNA of heart ventricles i olated from 
WKY 01 = 3) and age-matched SllR (n = 3) were subjected to 1% 
agaro~e gel elcctrophoresis and transferred to nylon membrane. The 
blots were then probed with a full-length radiolabeled Gig2 eDNA 
probe CA) or wah a full-length radiolabcled Gl~-3 eDNA probe (B) 
as described in section 2 
3. RESULTS AND DISCUSSION 
We have :ecently demonstrated the over expression 
of  Gkz in heart sarcolemma and aorta from SHR by 
PT-catalyzed ADP-ribosylation and immunoblotting 
techniques using specific antibodies against different 
isoforms of Gkz [15]. In the present studies we have 
investigated whether the enhanced levels of Gig protein 
observed previously in SHR were due to an increased 
synthesis of Gkz proteins. The abundance of the differ- 
ent mRNAs and rRNA was determined by Northern 
rather than dot blotting to ensure that we quantified 
only the probes bound to the specific transcript under 
all conditions. 
Tot.~! RNA of  heart ventricle was probed with radio- 
labelled eDNA inserts encoding for Gig2 and Gig3 
whiela are known to be expressed in rat heart [8,21]. The 
mRNA expression of Gi~2 and Gig3 are shown in Fig. 
1. The Gig2 probe (Fig. IA) detected a message of 2.3 
kb in both WKY and SHR, however, it was signifi- 
cantly more expressed in SHR as compared to WKY. 
The Gi~2 mRNA levels were found to be increased by 
about 60% in heart from SHR as compared to WKY 
(Fig. 2). Previous studies at the protein level have shown 
an about 50% increase in Gig2 levels [15], suggesting 
that the enhanced protein levels of Gig2 may be mainly 
attributed to an overexpression of Gi(x2 gone in heart 
from SHR. Similarly, the Gig3 probe (Fig. I B) hybrid- 
ized to a message of 3.5 kb and as observed for Gig2, 
the Gig3 mRNA levels were significantly higher in SHR 
as compared to WKY. Quantification of Gig3 mRNA 
in heart showed an about 120% increase in SHR as 
compared to WKY (Fig. 2) which does not match with 
an increase in Gi~3 at protein level (430%) as reported 
previously [15]. This observation is similar to the results 
reported in adipocxtes from streptozotocin-indu~d 
rats, where a large increase in Gi0~3 mRNA levels was 
not matched by increases at the protein level [22]. Sire- 
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Fi 8. 2 Summary of the quantification f Northern blot by den~lto- 
rnetr~e ~eannm$, Northern blot or total RNA from heart and aorta of 
SHR and WKY ratu were probed wRh radlolabelod eDNA probes as 
described m Section 2. Value~ obtained from the dens~tometne scans 
of the resultln~ autoradiograph~ were normalized relative to the 
amount of transcripts detected in the tissues from WKY rats which 
was arbitrarily assigned the value of 100%, The values for RNA from 
SHR ti~stte~ are siren a~ a pcreentalfie ofWKY value~ Results repre- 
sent he mean +- S.E.M. of 4 or 5 ~eparate experiments conducted with 
d~fferent preparauons of total RNA. 
A B 
Fig. 3. mRNA expr,'ssion of Gi~2 and Gi~3 in aorta from SHR and 
WgY rats. Total RNA of aortas isolated from WKY (n = 6) and 
al;e-lnatched SHR (n = 6) wer~ analyzed by Northern blotting as 
described in Fig. 1 The blots were hybridized w~th the G]~2 eDNA 
probe (A) or with the Gila3 eDNA probe (B) (upper panel~) and 
re-hybridized with an ohgonucleotide r cognizing the 28 S rRNA 
0ower panels). 
ilarly Watford and Tatro [23] have also shown an in- 
creased number of transcripts for intestinal phospho- 
enolpyruvate carboxykinase in diabetes without any 
comparable increase at the protein level. 
Since the aorta from SHR has been shown to exhibit 
similar alteration in the levels of Gi~ and adenylate 
cyclase activity as observed in heart [15], the mRNA 
expression of Gi~2 and Gi~3 was also examined in 
aortas from WKY and SHR and the results arc shown 
in Fig. 3. The Gin2 and Gig3 probes detected 2.3 kb and 
3.5 kb messages, respectively, in aorta from SHR and 
WKY, however, the Gi~2 (Fig. 3A) and Gin3 (Fig. 3B) 
mRNA levels were also significantly higher in SHR as 
compared to WKY. Densitometric analysis of the blots 
showed about 80% increase in Gi~2 mRNA levels and 
about 140% increase in Gkx3 mRNA levels in aorta 
from SHR (Fig. 2) A similar increase in Gi~x2 levels as 
determined by immunoblotting has been shown previ- 
ously [15], however, as observed in heart, the expression 
of Gkz3 mRNA in aorta is also much higher than the 
increase at the protein level [15]. The alterations in Gkx2 
and Gkx3 mRNA levels in heart and aorta from SHR 
may not be attributed to the variation in the amounts 
of total RNA in individual samples applied to the gels, 
due to the lhct that the hybridization with an oligonucle- 
otide that recognizes a highly conserved region of the 
28 S rRNA showed a similar amount of 28 S rRNA 
loaded from WKY and SHR on to the gels. These data 
sue, Best that the enhanced expression of Gi~ proteins in 
heart and aorta from SHR as reported earlier [15] may 
be regulated at the transcriptional level. The regulation 
of Gkx protein at transcriptional levels has also been 
reported in other conditions, such as diabetes [22] and 
human heart failure [24]. 
Since Gin-2 and not Gi~-3 is involved in the coupling 
of inhibitory hormone receptors to adenylate cyclase 
[25-27], the increased expression of Gin-2 in heart and 
aorta may partly explain the augmented responsiveness 
of adenylate yelase to inhibitory hormones in SHR 
[15]. On the other hand, Feldman et al. [24] were not 
able to detect Gi~-2 mRNA in hearts from human heart 
failure but, consistent with our studies, have reported 
an increased level ofGi~-3 mRNA and enhanced inhibi- 
tion of adenylate cyclase in these hearts. A role for 
Gkx-3 in gating K + channels has been established [28] 
and it would be interesting to examine if the increased 
levels of Gi~-3 mRNA in SHR are also reflected in its 
functions. 
We have also examined the Gscx protein expression 
at the transcriptional level in heart and aorta from 
WKY and SHR, and the mRNA levels of Gs~ were 
determined using a eDNA probe coding for Gsm As 
shown in Fig. 4, the Gs~ eDNA probe detected a mes- 
sage of 1.8 kb in heart (A) and aorta (B) from both SHR 
and WKY, and the amount of Gscx mRNA was not 
significantly different in SHR and WKY rats (Fig. 2). 
These results are consistent with our previous data indi- 
cating that the levels of Gscx were not altered in SHR 
tissues as compared to WKY. However, Feldman et al. 
[24] despite reporting no change in the levels of Gscx 
protein in human heart failure° have shown an altera- 
tion in Gsg mRNA levels in this model. On the other 
hand, Chen et ai. [29] have recently established a corre- 
lation between the decreased stimulation of adenylate 
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Fig. 4, mRNA expression of Gs~ in SHR and WKY heart ventricles 
and aortaa, As d¢~,cribed in Fig, 1, total RNA from heart ventricle~ 
from WKY and SHR were probed with a full-length radiolabeled Gs~z 
eDNA plebe (upper panel) and further e-hybridized with an oligonu- 
elect{de recognizing the 28 S rRNA (lower panel). Total RNAs from 
aorta from SHR and WKY aortas (B) were treated as indicated m Fl~ 
1. Blot~ were probed w,th Gs~ eDNA probe (up~r panel) and with 
the oligonucleotide r cognizing the 28 S rRNA {lower panel), 
c2/clase and the decreased level of Gsc¢ at the protein and 
mRNA levels in dog heart failure. Taken together, it is 
suggested that the expression of Gscx protein may be 
regulated by multiple mechanisms. 
In conclusion, the present studies and several other 
previous reports upport he idea that alteration in G- 
protein levels may result in altered signal transduction 
and thus have several implications tbr the development 
of different pathophysiological onditions, uch as car- 
diovascular diseases [30,31], diabetes [32], and hypothy- 
roidism [33]. To out" knowledge, the present study is the 
first report demonstrating alterations in G-proteins at 
mRNA levels in hypertension. Whether the alteration 
in G-protein results in or partly induces the elevation of 
blood pressure in SHR has still to be explored. Chert et 
al. [29], however~ have recently suggested that alteration 
in signal transduction may be involved in the genetic 
changes required for a cardiocyte to hypertrophy. In 
addition, different contractile and structural genes prin- 
cipally expressed in neonatal and fetal periods are 
knc,vn to be reactivated with the establishment of hy- 
pertrophy [34]. It is also known that hypertension is 
associated with alterations in the plasma levels of sev- 
eral hormones, such as eatecholamines and atrial 
natriuretic factor [35,36], which may regulate the gene 
expression of G-proteins. The regulation of G-protein 
expression by thyroid [37] and steroid [38,39] hormones 
has been demonstrated. Sims et al. [401 lmve recently 
reported an increased expression of Gi at the protein 
level by angiotensin fusion. In the light of these obser- 
va£ons, it would be exciting to explore whether the 
expression of G-proteins could be regulated by 
hormones and other factors which play an important 
role in the regulation of blood pressure. 
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